Bone fracture exacerbates murine ischemic cerebral injury

Anesthesiology

Volumn 118, Issue 6, 2013, Pages 1362-1372

  Degos, Vincent ^a,b   Maze, Mervyn ^a,c   Vacas, Susana ^a,c   Hirsch, Jan ^a   Guo, Yi ^d   Shen, Fanxia ^d   Jun, Kristine ^d   Van Rooijen, Nico ^d   Gressens, Pierre ^b   Young, William L ^e   Su, Hua ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b HÔPITAL ROBERT DEBRÉ   (France)

^c Programme for Advanced Medical Education   (Portugal)

^d VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD68 ANTIGEN; CLODRONIC ACID; HIGH MOBILITY GROUP B1 PROTEIN; INTERLEUKIN 1BETA; NEUTRALIZING ANTIBODY; TUMOR NECROSIS FACTOR ALPHA;

ADVERSE OUTCOME; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR DISORDER; BLOOD SAMPLING; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; CELL INFILTRATION; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DISEASE EXACERBATION; HEMISPHERE; MACROPHAGE; MALE; MICROGLIA; MIDDLE CEREBRAL ARTERY OCCLUSION; MOUSE; NERVE CELL NECROSIS; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; TIBIA FRACTURE;

ANIMALS; BRAIN; BRAIN INJURIES; CELL DEATH; DISEASE MODELS, ANIMAL; FRACTURES, BONE; INFARCTION, MIDDLE CEREBRAL ARTERY; MACROPHAGE ACTIVATION; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL;

EID: 84878648233     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/ALN.0b013e31828c23f8     Document Type: Article

References (34)

1. Donnan GA, Fisher M, Macleod M, Davis SM: Stroke. Lancet 2008; 371:1612-23
2. Sennerby U, Melhus H, Gedeborg R, Byberg L, Garmo H, Ahlbom A, Pedersen NL, Michaëlsson K: Cardiovascular diseases and risk of hip fracture. JAMA 2009; 302:1666-73
3. Lakshminarayan K, Schissel C, Anderson DC, Vazquez G, Jacobs DR Jr, Ezzeddine M, Luepker RV, Virnig BA: Fiveyear rehospitalization outcomes in a cohort of patients with acute ischemic stroke: Medicare linkage study. Stroke 2011; 42:1556-62
4. Kanis J, Oden A, Johnell O: Acute and long-term increase in fracture risk after hospitalization for stroke. Stroke 2001; 32:702-6
5. Sanders RD, Bottle A, Jameson SS, Mozid A, Aylin P, Edger L, Ma D, Reed MR, Walters M, Lees KR, Maze M: Independent preoperative predictors of outcomes in orthopedic and vascular surgery: The influence of time interval between an acute coronary syndrome or stroke and the operation. Ann Surg 2012; 255:901-7
6. Cibelli M, Fidalgo AR, Terrando N, Ma D, Monaco C, Feldmann M, Takata M, Lever IJ, Nanchahal J, Fanselow MS, Maze M: Role of interleukin-1beta in postoperative cognitive dysfunction. Ann Neurol 2010; 68:360-8
7. Terrando N, Monaco C, Ma D, Foxwell BM, Feldmann M, Maze M: Tumor necrosis factor-alpha triggers a cytokine cascade yielding postoperative cognitive decline. Proc Natl Acad Sci USA 2010; 107:20518-22
8. Terrando N, Brzezinski M, Degos V, Eriksson LI, Kramer JH, Leung JM, Miller BL, Seeley WW, Vacas S, Weiner MW, Yaffe K, Young WL, Xie Z, Maze M: Perioperative cognitive decline in the aging population. Mayo Clin Proc 2011; 86:885-93
9. Lange SS, Mitchell DL, Vasquez KM: High mobility group protein B1 enhances DNA repair and chromatin modification after DNA damage. Proc Natl Acad Sci USA 2008; 105:10320-5
10. Bianchi ME, Manfredi AA: High-mobility group box 1 (HMGB1) protein at the crossroads between innate and adaptive immunity. Immunol Rev 2007; 220:35-46
11. Hayakawa K, Qiu J, Lo EH: Biphasic actions of HMGB1 signaling in inflammation and recovery after stroke. Ann N Y Acad Sci 2010; 1207:50-7
12. Lo EH: T time in the brain. Nat Med 2009; 15:844-6
13. Chamorro A, Hallenbeck J: The harms and benefits of inflammatory and immune responses in vascular disease. Stroke 2006; 37:291-3
14. Saederup N, Cardona AE, Croft K, Mizutani M, Cotleur AC, Tsou CL, Ransohoff RM, Charo IF: Selective chemokine receptor usage by central nervous system myeloid cells in CCR2-red fluorescent protein knock-in mice. PLoS ONE 2010; 5:e13693
15. Tada Y, Kanematsu Y, Kanematsu M, Nuki Y, Liang EI, Wada K, Makino H, Hashimoto T: A mouse model of intracranial aneurysm: Technical considerations. Acta Neurochir Suppl 2011; 111:31-5
16. Van Rooijen N, Sanders A: Liposome mediated depletion of macrophages: Mechanism of action, preparation of liposomes and applications. J Immunol Methods 1994; 174:83-93
17. van Rooijen N, Bakker J, Sanders A: Transient suppression of macrophage functions by liposome-encapsulated drugs. Trends Biotechnol 1997; 15:178-85
18. Zhang L, Schallert T, Zhang ZG, Jiang Q, Arniego P, Li Q, Lu M, Chopp M: A test for detecting long-term sensorimotor dysfunction in the mouse after focal cerebral ischemia. J Neurosci Methods 2002; 117:207-14
19. Bouët V, Freret T, Toutain J, Divoux D, Boulouard M, Schumann-Bard P: Sensorimotor and cognitive deficits after transient middle cerebral artery occlusion in the mouse. Exp Neurol 2007; 203:555-67
20. Shen F, Walker EJ, Jiang L, Degos V, Li J, Sun B, Heriyanto F, Young WL, Su H: Coexpression of angiopoietin-1 with VEGF increases the structural integrity of the blood-brain barrier and reduces atrophy volume. J Cereb Blood Flow Metab 2011; 31:2343-51
21. Inácio AR, Ruscher K, Leng L, Bucala R, Deierborg T: Macrophage migration inhibitory factor promotes cell death and aggravates neurologic deficits after experimental stroke. J Cereb Blood Flow Metab 2011; 31:1093-106
22. Croisier E, Moran LB, Dexter DT, Pearce RK, Graeber MB: Microglial inflammation in the parkinsonian substantia nigra: Relationship to alpha-synuclein deposition. J Neuroinflammation 2005; 2:14
23. Tsung A, Sahai R, Tanaka H, Nakao A, Fink MP, Lotze MT, Yang H, Li J, Tracey KJ, Geller DA, Billiar TR: The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion. J Exp Med 2005; 201:1135-43
24. Kim JY, Park JS, Strassheim D, Douglas I, Diaz del Valle F, Asehnoune K, Mitra S, Kwak SH, Yamada S, Maruyama I, Ishizaka A, Abraham E: HMGB1 contributes to the development of acute lung injury after hemorrhage. Am J Physiol Lung Cell Mol Physiol 2005; 288:L958-65
25. Levy RM, Mollen KP, Prince JM, Kaczorowski DJ, Vallabhaneni R, Liu S, Tracey KJ, Lotze MT, Hackam DJ, Fink MP, Vodovotz Y, Billiar TR: Systemic inflammation and remote organ injury following trauma require HMGB1. Am J Physiol Regul Integr Comp Physiol 2007; 293:R1538-44
26. Coutinho ES, Fletcher A, Bloch KV, Rodrigues LC: Risk factors for falls with severe fracture in elderly people living in a middleincome country: A case control study. BMC Geriatr 2008; 8:21
27. Myint PK, Poole KE, Warburton EA: Hip fractures after stroke and their prevention. QJM 2007; 100:539-45
28. Alberti A, Agnelli G, Caso V, Venti M, Acciarresi M, D'Amore C, Paciaroni M: Non-neurological complications of acute stroke: Frequency and influence on clinical outcome. Intern Emerg Med 2011; 6:119-23
29. Emsley HC, Hopkins SJ: Acute ischaemic stroke and infection: Recent and emerging concepts. Lancet Neurol 2008; 7:341-53
30. Smith CJ, Emsley HC, Gavin CM, Georgiou RF, Vail A, Barberan EM, del Zoppo GJ, Hallenbeck JM, Rothwell NJ, Hopkins SJ, Tyrrell PJ: Peak plasma interleukin-6 and other peripheral markers of inflammation in the first week of ischaemic stroke correlate with brain infarct volume, stroke severity and long-term outcome. BMC Neurol 2004; 4:2
31. Byrnes KR, Stoica B, Loane DJ, Riccio A, Davis MI, Faden AI: Metabotropic glutamate receptor 5 activation inhibits microglial associated inflammation and neurotoxicity. Glia 2009; 57:550-60
32. Kaindl AM, Degos V, Peineau S, Gouadon E, Chhor V, Loron G, Le Charpentier T, Josserand J, Ali C, Vivien D, Collingridge GL, Lombet A, Issa L, Rene F, Loeffler JP, Kavelaars A, Verney C, Mantz J, Gressens P: Activation of microglial N-methyl-D-aspartate receptors triggers inflammation and neuronal cell death in the developing and mature brain. Ann Neurol 2012; 72:536-49
33. Muhammad S, Barakat W, Stoyanov S, Murikinati S, Yang H, Tracey KJ, Bendszus M, Rossetti G, Nawroth PP, Bierhaus A, Schwaninger M: The HMGB1 receptor RAGE mediates ischemic brain damage. J Neurosci 2008; 28:12023-31
34. Shichita T, Hasegawa E, Kimura A, Morita R, Sakaguchi R, Takada I, Sekiya T, Ooboshi H, Kitazono T, Yanagawa T, Ishii T, Takahashi H, Mori S, Nishibori M, Kuroda K, Akira S, Miyake K, Yoshimura A: Peroxiredoxin family proteins are key initiators of post-ischemic inflammation in the brain. Nat Med 2012; 18:911-7